Memorial Sloan-Kettering Cancer Center (Mskcc) - New York

New York, New York 10065-6007

3 studies enrolling now · 9 studies all time

What they study most

Advanced Solid Tumor, Breast Cancer, Chronic Lymphocytic Leukemia, Endogenous Cushing's Syndrome, Extensive-stage Small-cell Lung Cancer, Locally Advanced Rectal Cancer, Locally Advanced or Unresectable Metastatic Breast Cancer, Lymphoma, Small Lymphocytic, Non-Hodgkin Lymphoma, Stage IV Breast Cancer

Studies at this site

• A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma — Recruiting now
• A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma — Recruiting now
• A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib — Recruiting now
• A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors — Running, not enrolling
• DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02] — Completed
• Ifinatamab Deruxtecan (I-DXd) in Subjects With Pretreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC) — Running, not enrolling
• Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome — Running, not enrolling
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy — Running, not enrolling
• Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer — Completed